IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

Vincenzo Bronte, Paolo Serafini, Carmela De Santo, Ilaria Marigo, Valeria Tosello, Alessandra Mazzoni, David M. Segal, Caroline Staib, Marianne Lowel, Gerd Sutter, Mario P. Colombo, Paola Zanovello

Research output: Contribution to journalArticle

327 Citations (Scopus)

Abstract

We previously demonstrated that a specialized subset of immature myeloid cells migrate to lymphoid organs as a result of tumor growth or immune stress, where they suppress B and T cell responses to Ags. Although NO was required for suppression of mitogen activation of T cells by myeloid suppressor cells (MSC), it was not required for suppression of allogenic responses. In this study, we describe a novel mechanism used by MSC to block T cell proliferation and CTL generation in response to alloantigen, which is mediated by the enzyme arginase 1 (Arg1). We show that Arg1 increases superoxide production in myeloid cells through a pathway that likely utilizes the reductase domain of inducible NO synthase (iNOS), and that superoxide is required for Arg1-dependent suppression of T cell function. Arg1 is induced by IL-4 in freshly isolated MSC or cloned MSC lines, and is therefore up-regulated by activated Th2, but not Th1, cells. In contrast, iNOS is induced by IFN-γ and Th1 cells. Because Arg1 and iNOS share L-arginine as a common substrate, our results indicate that L-arginine metabolism in myeloid cells is a potential target for selective intervention in reversing myeloid-induced dysfunction in tumor-bearing hosts.

Original languageEnglish
Pages (from-to)270-278
Number of pages9
JournalJournal of Immunology
Volume170
Issue number1
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Arginase
Myeloid Cells
Interleukin-4
T-Lymphocytes
Neoplasms
Nitric Oxide Synthase
Th1 Cells
Superoxides
Arginine
Isoantigens
Mitogens
Oxidoreductases
B-Lymphocytes
Cell Proliferation
Cell Line
Enzymes
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., ... Zanovello, P. (2003). IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. Journal of Immunology, 170(1), 270-278.

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. / Bronte, Vincenzo; Serafini, Paolo; De Santo, Carmela; Marigo, Ilaria; Tosello, Valeria; Mazzoni, Alessandra; Segal, David M.; Staib, Caroline; Lowel, Marianne; Sutter, Gerd; Colombo, Mario P.; Zanovello, Paola.

In: Journal of Immunology, Vol. 170, No. 1, 01.01.2003, p. 270-278.

Research output: Contribution to journalArticle

Bronte, V, Serafini, P, De Santo, C, Marigo, I, Tosello, V, Mazzoni, A, Segal, DM, Staib, C, Lowel, M, Sutter, G, Colombo, MP & Zanovello, P 2003, 'IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice', Journal of Immunology, vol. 170, no. 1, pp. 270-278.
Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. Journal of Immunology. 2003 Jan 1;170(1):270-278.
Bronte, Vincenzo ; Serafini, Paolo ; De Santo, Carmela ; Marigo, Ilaria ; Tosello, Valeria ; Mazzoni, Alessandra ; Segal, David M. ; Staib, Caroline ; Lowel, Marianne ; Sutter, Gerd ; Colombo, Mario P. ; Zanovello, Paola. / IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. In: Journal of Immunology. 2003 ; Vol. 170, No. 1. pp. 270-278.
@article{2a66cb75c8eb493d97f2ada7cd9b7c23,
title = "IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice",
abstract = "We previously demonstrated that a specialized subset of immature myeloid cells migrate to lymphoid organs as a result of tumor growth or immune stress, where they suppress B and T cell responses to Ags. Although NO was required for suppression of mitogen activation of T cells by myeloid suppressor cells (MSC), it was not required for suppression of allogenic responses. In this study, we describe a novel mechanism used by MSC to block T cell proliferation and CTL generation in response to alloantigen, which is mediated by the enzyme arginase 1 (Arg1). We show that Arg1 increases superoxide production in myeloid cells through a pathway that likely utilizes the reductase domain of inducible NO synthase (iNOS), and that superoxide is required for Arg1-dependent suppression of T cell function. Arg1 is induced by IL-4 in freshly isolated MSC or cloned MSC lines, and is therefore up-regulated by activated Th2, but not Th1, cells. In contrast, iNOS is induced by IFN-γ and Th1 cells. Because Arg1 and iNOS share L-arginine as a common substrate, our results indicate that L-arginine metabolism in myeloid cells is a potential target for selective intervention in reversing myeloid-induced dysfunction in tumor-bearing hosts.",
author = "Vincenzo Bronte and Paolo Serafini and {De Santo}, Carmela and Ilaria Marigo and Valeria Tosello and Alessandra Mazzoni and Segal, {David M.} and Caroline Staib and Marianne Lowel and Gerd Sutter and Colombo, {Mario P.} and Paola Zanovello",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "170",
pages = "270--278",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

AU - Bronte, Vincenzo

AU - Serafini, Paolo

AU - De Santo, Carmela

AU - Marigo, Ilaria

AU - Tosello, Valeria

AU - Mazzoni, Alessandra

AU - Segal, David M.

AU - Staib, Caroline

AU - Lowel, Marianne

AU - Sutter, Gerd

AU - Colombo, Mario P.

AU - Zanovello, Paola

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We previously demonstrated that a specialized subset of immature myeloid cells migrate to lymphoid organs as a result of tumor growth or immune stress, where they suppress B and T cell responses to Ags. Although NO was required for suppression of mitogen activation of T cells by myeloid suppressor cells (MSC), it was not required for suppression of allogenic responses. In this study, we describe a novel mechanism used by MSC to block T cell proliferation and CTL generation in response to alloantigen, which is mediated by the enzyme arginase 1 (Arg1). We show that Arg1 increases superoxide production in myeloid cells through a pathway that likely utilizes the reductase domain of inducible NO synthase (iNOS), and that superoxide is required for Arg1-dependent suppression of T cell function. Arg1 is induced by IL-4 in freshly isolated MSC or cloned MSC lines, and is therefore up-regulated by activated Th2, but not Th1, cells. In contrast, iNOS is induced by IFN-γ and Th1 cells. Because Arg1 and iNOS share L-arginine as a common substrate, our results indicate that L-arginine metabolism in myeloid cells is a potential target for selective intervention in reversing myeloid-induced dysfunction in tumor-bearing hosts.

AB - We previously demonstrated that a specialized subset of immature myeloid cells migrate to lymphoid organs as a result of tumor growth or immune stress, where they suppress B and T cell responses to Ags. Although NO was required for suppression of mitogen activation of T cells by myeloid suppressor cells (MSC), it was not required for suppression of allogenic responses. In this study, we describe a novel mechanism used by MSC to block T cell proliferation and CTL generation in response to alloantigen, which is mediated by the enzyme arginase 1 (Arg1). We show that Arg1 increases superoxide production in myeloid cells through a pathway that likely utilizes the reductase domain of inducible NO synthase (iNOS), and that superoxide is required for Arg1-dependent suppression of T cell function. Arg1 is induced by IL-4 in freshly isolated MSC or cloned MSC lines, and is therefore up-regulated by activated Th2, but not Th1, cells. In contrast, iNOS is induced by IFN-γ and Th1 cells. Because Arg1 and iNOS share L-arginine as a common substrate, our results indicate that L-arginine metabolism in myeloid cells is a potential target for selective intervention in reversing myeloid-induced dysfunction in tumor-bearing hosts.

UR - http://www.scopus.com/inward/record.url?scp=0037223170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037223170&partnerID=8YFLogxK

M3 - Article

C2 - 12496409

AN - SCOPUS:0037223170

VL - 170

SP - 270

EP - 278

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -